Tirzepatide (98% Purity)

This product is currently out of stock and unavailable.

SKU: PEP-tirzepatide-98%-purity Category:
Description

Description

Rate this product

Short Overview

Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide for research into incretin signaling, metabolic regulation, and glucose homeostasis.

Product Specifications

  • Product Name: Tirzepatide
  • Category: Peptide
  • CAS Number: 2023788-19-2
  • Form: Lyophilized Powder
  • Purity: 98% (HPLC)
  • Storage: Store at -20°C to 2-8°C, protected from light and moisture

Available Variants

SizePackaging
5 gSealed Vial
10 gSealed Vial
15 gSealed Vial
20 gSealed Vial
30 gSealed Vial

Key Features

  • High purity research-grade quality (98% by HPLC)
  • Lyophilized powder form for optimal stability
  • Consistent batch-to-batch reliability with COA
  • Secure tamper-evident sealed vial packaging
  • Suitable for qualified laboratory research only

Research Applications

  • Dual GIP/GLP-1 receptor co-agonism mechanism studies
  • Incretin-based glucose regulation and insulin secretion research
  • Body weight management and adipose tissue metabolism studies
  • Comparative efficacy analysis with mono-agonist peptides
  • Beta-cell function preservation and regeneration research
  • Pharmacodynamic modeling of dual-agonist peptide therapies

Handling and Storage

  • Store lyophilized peptide at -20°C for long-term stability
  • Reconstituted solutions should be stored at 2-8°C and used within recommended timeframe
  • Avoid repeated freeze-thaw cycles to preserve compound integrity
  • Handle under dry, inert conditions to prevent degradation

Important Disclaimer

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical, veterinary, or household use.

Additional information

Additional information

Pack Size5g Vial, 10g Vial, 15g Vial, 20g Vial, 30g Vial
Reviews (0)

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.